IRIS
MORI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.236
EU - Europa 7.783
AS - Asia 4.900
SA - Sud America 1.315
Continente sconosciuto - Info sul continente non disponibili 624
AF - Africa 256
OC - Oceania 12
Totale 25.126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.061
IT - Italia 1.936
RU - Federazione Russa 1.647
SG - Singapore 1.644
CN - Cina 1.277
GB - Regno Unito 1.172
BR - Brasile 1.075
IE - Irlanda 1.012
VN - Vietnam 689
FR - Francia 495
HK - Hong Kong 493
SE - Svezia 351
DE - Germania 337
UA - Ucraina 336
KR - Corea 183
FI - Finlandia 176
IN - India 138
BD - Bangladesh 122
AR - Argentina 113
ZA - Sudafrica 105
CA - Canada 92
TR - Turchia 57
ES - Italia 54
NL - Olanda 47
MX - Messico 46
CZ - Repubblica Ceca 40
IQ - Iraq 40
ID - Indonesia 38
PL - Polonia 38
PK - Pakistan 35
EC - Ecuador 34
JP - Giappone 34
AT - Austria 31
CI - Costa d'Avorio 26
KE - Kenya 26
CO - Colombia 24
SA - Arabia Saudita 23
CL - Cile 21
NG - Nigeria 20
BE - Belgio 19
MA - Marocco 18
EG - Egitto 17
VE - Venezuela 16
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
TN - Tunisia 14
DZ - Algeria 12
IR - Iran 12
JO - Giordania 12
PT - Portogallo 11
PY - Paraguay 11
UZ - Uzbekistan 10
AU - Australia 9
AZ - Azerbaigian 9
GR - Grecia 9
MY - Malesia 9
PE - Perù 9
NP - Nepal 8
UY - Uruguay 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
EU - Europa 7
IL - Israele 6
JM - Giamaica 6
KZ - Kazakistan 6
SC - Seychelles 6
AL - Albania 5
BY - Bielorussia 5
LT - Lituania 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
CY - Cipro 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
PA - Panama 4
RO - Romania 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
GE - Georgia 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
QA - Qatar 3
SI - Slovenia 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
Totale 24.480
Salva come PNG Salva come JPEG
Città #
Dallas 1.621
Southend 1.012
Dublin 1.006
Fairfield 941
Ashburn 834
Singapore 823
Milan 599
Woodbridge 477
Hong Kong 468
Moscow 456
Seattle 419
Beijing 397
Council Bluffs 364
Chandler 353
Wilmington 351
San Jose 349
Houston 343
Cambridge 328
Siena 310
Santa Clara 307
Rome 227
Hefei 224
Jacksonville 224
Ann Arbor 207
Ho Chi Minh City 206
Menlo Park 201
Princeton 200
Seoul 182
Los Angeles 157
Hanoi 154
Lauterbourg 149
The Dalles 137
New York 135
San Mateo 97
Munich 91
Helsinki 87
São Paulo 86
Johannesburg 76
Buffalo 71
San Diego 69
Nanjing 65
Boardman 63
Columbus 62
Dong Ket 62
Redwood City 60
Figino 56
Florence 49
Bengaluru 42
Redondo Beach 42
Shanghai 42
Lappeenranta 41
Fremont 39
Chicago 37
London 37
Turin 36
Rio de Janeiro 35
Phoenix 32
Nuremberg 29
Brno 28
San Francisco 28
Tokyo 28
Haiphong 27
Abidjan 26
Frankfurt am Main 26
Izmir 24
Montreal 24
Orem 24
Nanchang 23
Düsseldorf 22
Baghdad 21
Chennai 21
Da Nang 21
Salamanca 21
Boston 20
Brooklyn 20
Shenyang 20
Warsaw 20
Belo Horizonte 19
Brussels 19
Naples 19
Norwalk 19
Brasília 18
Hải Dương 18
Jinan 18
Abuja 17
Atlanta 17
Washington 17
Curitiba 16
Denver 16
Mexico City 16
Toronto 16
Bologna 15
Dearborn 15
Guangzhou 15
Buenos Aires 14
Turku 14
Dhaka 13
Mumbai 13
Málaga 13
Salvador 13
Totale 16.381
Salva come PNG Salva come JPEG
Nome #
Biological Evaluation and Computational Modelling Studies on N-acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents 506
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 412
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 349
Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update 308
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 303
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains 301
Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions 293
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 291
Tautomers of a Fluorescent G Surrogate and Their Distinct Photophysics Provide Additional Information Channels 276
Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII 274
Differentially activated Src kinase in chemo-naive human primary osteosarcoma cells and effects of a Src kinase inhibitor 274
In Memory of Maurizio Botta: His Contribution to the Development of Computer-Aided Drug Design 271
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 267
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein Interaction 264
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 263
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case 259
Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 257
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 254
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro 244
Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing 241
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein 240
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 232
Molecular Dynamics and DFT Study on HIV-1 Nucleocapsid Protein-7 in Complex with Viral Genome 228
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor 227
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors 227
Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein 225
Small molecules modulation of 14-3-3 protein–protein interactions 223
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 217
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 216
A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds 209
Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations 205
Multitarget hedgehog pathway inhibitors and uses thereof 198
Structure Prediction and Validation of the ERK8 Kinase Domain 196
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone 190
Free energy profile and kinetics studies of paclitaxel internalization from the outer to the inner wall of microtubules 188
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors 188
Hedgehog Pathway Inhibition by Novel Small Molecules Impairs Melanoma Cell Migration and Invasion under Hypoxia 186
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines 184
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma 183
Probing the Pore Drug Binding Site ofMicrotubules with Fluorescent Taxanes:Evidence of Two Binding Poses 182
Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein 181
Predicting the Binding Mode of Known NCp7 Inhibitors To Facilitate the Design of Novel Modulators 179
Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulators 179
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge 177
A smo/gli multitarget hedgehog pathway inhibitor impairs tumor growth 173
Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy 173
Nigritanine as a new potential antimicrobial alkaloid for the treatment of staphylococcus aureus-induced infections 173
Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (PtpB) inhibitors from natural products 167
Nucleocapsid protein: A desirable target for future therapies against HIV-1 167
Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161PPI Interface 167
Natural products inspired modulators of cancer stem cells-specific signaling pathways notch and hedgehog 166
A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome 163
A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1 161
Targeting GLI factors to inhibit the Hedgehog pathway 157
A unique high-diversity natural product collection as a reservoir of new therapeutic leads 156
Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity 155
Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities 155
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment 152
14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban 151
A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia 150
Oregonin from Alnus incana bark affects DNA methyltransferases expression and mitochondrial DNA copies in mouse embryonic fibroblasts 149
Current trends in Hedgehog signaling pathway inhibition by small molecules 145
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 144
A deadly spillover: SARS-CoV-2 outbreak 143
Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia 142
Statins interfere with the attachment of S. cerevisiae mtDNA to the inner mitochondrial membrane 141
Histone demethylating agents as potential S-adenosyl-l-methionine-competitors 141
Conformational insights into the C-terminal mutations of human rhodopsin in retinitis pigmentosa 141
Thienoguanosine, a unique non-perturbing reporter for investigating rotational dynamics of DNA duplexes and their complexes with proteins 138
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 138
P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation 138
INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T 138
Excited-State Dynamics of Thienoguanosine, an Isomorphic Highly Fluorescent Analogue of Guanosine 136
Yeast as a tool to select inhibitors of the cullin deneddylating enzyme Csn5 136
Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold 136
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells 136
Selective targeting of cancer-related G-Quadruplex structures by the natural compound dicentrine 135
Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells 134
Natural flavonoid derivatives have pan-Coronavirus antiviral activity 133
Synthesis of distal and proximal fleximer base analogues and evaluation in the nucleocapsid protein of HIV-1 133
What makes thienoguanosine an outstanding fluorescent DNA probe? 132
Hedgehog signaling pathway inhibitors: an updated patent review (2015–present) 131
Natural products as an important source in drug discovery 131
Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells 130
Targeting the nucleocapsid protein of HIV-1 (NCp7) with nucleobase flexibility 129
Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors 128
Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein 126
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 124
Molecular Dynamics Simulations and Structural Analysis of Giardia Duodenalis 14-3-3 Protein-Protein Interactions 124
Ent-Beyerane Diterpenes as a Key Platform for the Development of ArnT-Mediated Colistin Resistance Inhibitors 124
Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action 124
Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia 122
One hundred faces of cyclopamine 122
Antimalarial drugs: what's new in the patents? 121
Novel insights on human carbonic anhydrase inhibitors based on coumalic acid: design, synthesis, molecular modeling investigation, and biological studies 121
DNA and RNA polymerases 119
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold 119
Synthesis of flexible purine analog inhibitors of NCp7 118
In Memory of Maurizio Botta: His Vision of Medicinal Chemistry 118
Dual SMO/BRAF inhibition by flavonolignans from Silybum marianum† 118
Totale 18.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.391 0 183 148 30 51 89 75 53 119 154 176 313
2022/20231.669 144 172 249 237 95 351 33 119 142 37 44 46
2023/20241.725 48 32 130 139 39 395 518 60 13 38 51 262
2024/20253.726 118 262 264 280 279 185 148 162 336 272 382 1.038
2025/20269.983 671 1.304 1.588 1.258 1.480 271 860 270 350 496 446 989
2026/2027703 437 266 0 0 0 0 0 0 0 0 0 0
Totale 25.126